Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Comprehensive Characterization of Rare Recurrent Mutations in Pediatric AML

Adam Lamble, Rhonda E. Ries, Jack H. Peplinski, Logan K. Wallace, Danielle C. Kirkey, Xiaotu Ma, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 849.

https://doi.org/10.1182/blood-2024-208864

Published: 2024

Journal Articles

Haplo-Insufficiency of RAS Genes Is the Determinant of Outcome in AML

Jack H. Peplinski, Logan K. Wallace, Rhonda E. Ries, Xiaotu Ma, Danielle C. Kirkey, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 1562.

https://doi.org/10.1182/blood-2024-208953

Published: 2024

Journal Articles

Germline Variant Burden Warrants Universal Genetic Testing in Pediatric AML

Lauren Harmon, Zachary S Hattig, Yizhou Peter Huang, Caliese Beckford, Xiaotu Ma, Rhonda E. Ries, Soheil Meshinchi, Lucy Godley, Timothy J Triche, Jr.

Blood (2024) 144 (Supplement 1): 4092.

https://doi.org/10.1182/blood-2024-210515

Published: 2024

Journal Articles

Dysregulation of Developmental Transcription Factors in Acute Myeloid Leukemia Predicts Poor Outcome and Impacts Adaptive Immune Pathway Genes

Logan K. Wallace, Jack H. Peplinski, Rhonda E. Ries, Danielle C. Kirkey, Xiaotu Ma, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 638.

https://doi.org/10.1182/blood-2024-194524

Published: 2024

Journal Articles

The Role of an Inflammatory Phenotype in Driving Clonal Evolution in B-Acute Lymphoblastic Leukemia

Danielle Wolfe Cohen, Clemence Aldebert, Emily Duan, Sylwia Jasinski, Xiaotu Ma, Heather L. Mulder, John Easton, Jiyuan Hu, Laura E. Hogan, David T. Teachey, Elizabeth A. Raetz, Nikki Evensen, William L. Carroll

Blood (2024) 144 (Supplement 1): 633.

https://doi.org/10.1182/blood-2024-205379

Published: 2024

Journal Articles

Cancer Genomic Profiling and Minimal Residual Disease Monitoring By Cell-Free DNA Sequencing in Pediatric Leukemia

Shaohua Lei, Sujuan Jia, Sunitha Takalkar, Ti-Cheng Chang, Gang Wu, Xiaotu Ma, Selene C. Koo, Paul E. Mead, Jeffery M. Klco, Ruth G. Tatevossian, Charles G. Mullighan

Blood (2023) 142 (Supplement 1): 1604.

https://doi.org/10.1182/blood-2023-188158

Published: 2023

Journal Articles

Identification of a Relapse Signature in t(8;21) Pediatric AML

Logan K Wallace, Jack H Peplinski, Rhonda E Ries, Benjamin J Huang, Xiaotu Ma, Scott N Furlan, Danielle C Kirkey, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 4318.

https://doi.org/10.1182/blood-2023-189817

Published: 2023

Journal Articles

UBTF Tandem Duplications in Pediatric MDS and AML: Implications for Clinical Screening and Diagnosis

Juan Barajas, Masayuki Umeda, Jing Ma, Mahsa Khanlari, Michael P Walsh, Tamara Westover, Lisett Contreras, Guangchun Song, Xiaotu Ma, Melvin Thomas, III, Jeffery M. Klco

Blood (2023) 142 (Supplement 1): 838.

https://doi.org/10.1182/blood-2023-172765

Published: 2023

Journal Articles

DNMT3A Mutants Are Enriched in NPMc+ AML and Associated with Adverse Outcome in Childhood AML

Rhonda E Ries, Xiaotu Ma, Claudia Tregnago, Todd A. Alonzo, Jim Wang, Tiffany Hylkema, Benjamin J Huang, Alireza Torabi, Jack H Peplinski, Logan K Wallace, Richard Aplenc, Alan S Gamis, Katherine Tarlock, Franco Locatelli, Martina Pigazzi, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 4306.

https://doi.org/10.1182/blood-2023-181060

Published: 2023

Journal Articles

Integrative Genome and Transcriptome Sequencing Analysis Indicates Genetic and Epigenetic Dysregulation in DS-AML

Xiaotu Ma, Rhonda E Ries, Quang Tran, Yanling Liu, Pandurang Kolekar, Ramzi Alsallaq, Zhikai Liang, Timothy Shaw, Meghana Devineni, Anne Deslattes Mays, Ching Lau, Johann K. Hitzler, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 4117.

https://doi.org/10.1182/blood-2023-186456

Published: 2023

Journal Articles

Integrated Methylation and Transcriptional Landscape and Evolution of Pediatric AML

Benjamin J Huang, Hamid Bolouri, Colin Y. Smith, Jim Wang, Rhonda E Ries, Elizabeth Conran, Alan S Gamis, Richard Aplenc, Todd A. Alonzo, Xiaotu Ma, Timothy Junius Triche, Jason E Farrar, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 2956.

https://doi.org/10.1182/blood-2023-187819

Published: 2023

Journal Articles

Identifying a Relapse Signature in CBFB-MYH11 Acute Myeloid Leukemia

Jack H Peplinski, Logan K Wallace, Rhonda E Ries, Benjamin J Huang, Amanda R Leonti, Danielle C Kirkey, Xiaotu Ma, Scott N Furlan, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 2955.

https://doi.org/10.1182/blood-2023-187637

Published: 2023

Journal Articles

CREBBP alterations are associated with a poor prognosis in de novo AML

Adam J. Lamble, Kohei Hagiwara, Robert B. Gerbing, Jenny L. Smith, Pandurang Kolekar, Rhonda E. Ries, Edward A. Kolb, Todd A. Alonzo, Xiaotu Ma, Soheil Meshinchi

Blood (2023) 141 (17): 2156–2159.

https://doi.org/10.1182/blood.2022017545

Published: 2023

Includes: Supplemental data

Journal Articles

Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions

Blood (2023) 141 (7): 800–805.

https://doi.org/10.1182/blood.2022017874

Published: 2023

Includes: Supplemental data

Journal Articles

Subtype Dependent Drug Resistance Alterations in Relapsed Childhood B-ALL: A Children's Oncology Group Study

Xiaotu Ma, Lingyun Ji, Yanling Liu, Ying Shao, Heather Mulder, Pandurang Kolekar, Quang Tran, Jinghui Zhang, John Easton, William L. Carroll, Patrick A. Brown, Mignon L. Loh

Blood (2022) 140 (Supplement 1): 1048–1049.

https://doi.org/10.1182/blood-2022-166489

Published: 2022

Journal Articles

Tracking Clonal Evolution in Pediatric AML

Anna LW Huskey, Pandurang Kolekar, Tamara Westover, Jing Ma, Michael P Walsh, Masayuki Umeda, Guangchun Song, Yanling Liu, Quang Tran, Xiaotu Ma, Jeffery M. Klco

Blood (2022) 140 (Supplement 1): 8686–8687.

https://doi.org/10.1182/blood-2022-167256

Published: 2022

Journal Articles

Transcriptome Analysis and Machine Learning Prioritize Therapeutic Strategies for High-Risk Pediatric AML Patients of the KMT2A-Fusion Subgroup

Alyssa Obermayer, Sijie Yao, Jenny L. Smith, Rhonda E. Ries, Yi-Cheng Wang, Jason E Farrar, Scott N Furlan, Tim Triche, Xiaotu Ma, Benjamin J. Huang, Xuefeng Wang, Soheil Meshinchi, Timothy I. Shaw

Blood (2022) 140 (Supplement 1): 3385–3386.

https://doi.org/10.1182/blood-2022-163616

Published: 2022

Journal Articles

Pathogenic TP53 mutations Are Associated with a Poor Prognosis in De Novo AML

Adam J. Lamble, Rhonda E. Ries, Alice Dang, Todd A. Alonzo, Karen Chisholm, Pandurang Kolekar, Yanling Liu, Quang Tran, Todd M. Cooper, Richard Aplenc, Alan S. Gamis, Edward A. Kolb, Xiaotu Ma, Soheil Meshinchi

Blood (2022) 140 (Supplement 1): 6297–6298.

https://doi.org/10.1182/blood-2022-162832

Published: 2022

Journal Articles

A Robust Long Non-Coding RNA Expression Classifier for Risk Stratification in Pediatric AML

Jason E Farrar, Jenny L. Smith, Megan Othus, Benjamin J. Huang, Yi-Cheng Wang, Rhonda E. Ries, Tiffany A. Hylkema, Era L Pogosova-Agadjanyan, Sneha Challa, Amanda R. Leonti, Timothy I. Shaw, Timothy Junius Triche, Jr., Alan S. Gamis, Richard Aplenc, Anders E. Kolb, Xiaotu Ma, Derek Stirewalt, Todd A. Alonzo, Soheil Meshinchi

Blood (2022) 140 (Supplement 1): 9173–9174.

https://doi.org/10.1182/blood-2022-168296

Published: 2022

Journal Articles

Integrated Genomic Analysis Identifies UBTF Tandem Duplications As a Subtype-Defining Lesion in Pediatric Acute Myeloid Leukemia

Blood (2021) 138 (Supplement 2): LBA-4.

https://doi.org/10.1182/blood-2021-155134

Published: 2021

NARROW

Comprehensive Characterization of Rare Recurrent Mutations in Pediatric AML

Haplo-Insufficiency of RAS Genes Is the Determinant of Outcome in AML

Germline Variant Burden Warrants Universal Genetic Testing in Pediatric AML

Dysregulation of Developmental Transcription Factors in Acute Myeloid Leukemia Predicts Poor Outcome and Impacts Adaptive Immune Pathway Genes

The Role of an Inflammatory Phenotype in Driving Clonal Evolution in B-Acute Lymphoblastic Leukemia

Cancer Genomic Profiling and Minimal Residual Disease Monitoring By Cell-Free DNA Sequencing in Pediatric Leukemia

Identification of a Relapse Signature in t(8;21) Pediatric AML

UBTF Tandem Duplications in Pediatric MDS and AML: Implications for Clinical Screening and Diagnosis

DNMT3A Mutants Are Enriched in NPMc+ AML and Associated with Adverse Outcome in Childhood AML

Integrative Genome and Transcriptome Sequencing Analysis Indicates Genetic and Epigenetic Dysregulation in DS-AML

Integrated Methylation and Transcriptional Landscape and Evolution of Pediatric AML

Identifying a Relapse Signature in CBFB-MYH11 Acute Myeloid Leukemia

CREBBP alterations are associated with a poor prognosis in de novo AML

Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions

Subtype Dependent Drug Resistance Alterations in Relapsed Childhood B-ALL: A Children's Oncology Group Study

Tracking Clonal Evolution in Pediatric AML

Transcriptome Analysis and Machine Learning Prioritize Therapeutic Strategies for High-Risk Pediatric AML Patients of the KMT2A-Fusion Subgroup

Pathogenic TP53 mutations Are Associated with a Poor Prognosis in De Novo AML

A Robust Long Non-Coding RNA Expression Classifier for Risk Stratification in Pediatric AML

Integrated Genomic Analysis Identifies UBTF Tandem Duplications As a Subtype-Defining Lesion in Pediatric Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only